MIRacle™ mmu-miR-34b-5p miRNA Agomir/Antagomir

Description

MIRacle™ mmu-miR-34b-5p miRNA Agomir/Antagomir is a chemically modified synthetic oligonucleotide developed to precisely modulate the activity of endogenous microRNAs. The Agomir functions as a miRNA mimic, effectively enhancing the expression and biological activity of mmu-miR-34b-5p. Whereas the Antagomir serves as a sequence-specific antagonist, inhibiting mmu-miR-34b-5p function. Both formulations are optimized for high stability and efficacy in in vitro and in vivo settings. AcceGen provides the MIRacle™ series in multiple specifications (2 OD, 4 OD, 50 OD) with HPLC purification to accommodate a diverse range of experimental requirements. These reagents are ideal for investigating the role of target miRNA in key biological processes including colorectal cancer development and progression. In advanced applications, MIRacle™ mmu-miR-34b-5p products, including Agomir and Antagomir formats, are core tools in miRNA agomir/antagomir strategies for MIRacle miRNA therapeutic development, enabling systematic analysis of miR-34b-5p function, gene regulation, expression, and its role in cancer through the proprietary MIRacle miRNA platform.